Swift Biosciences
In Brief This Week: Abbott Laboratories, LexaGene, Caris Life Sciences, SQI Diagnostics, and More
News items for the in vitro diagnostics industry for the week of March 1, 2021.
Swift Biosciences, BillionToOne Partner to Commercialize COVID-19 Test
BillionToOne's assay detects SARS-CoV-2 in samples from nasal, nasopharyngeal, and oropharyngeal swabs and has a testing capacity of 1 million tests per day.